Sustainability | January 07, 2026
WuXi Biologics secures ISO 20400 certification
WuXi Biologics has integrated sustainability principles throughout its supplier lifecycle management
WuXi Biologics has integrated sustainability principles throughout its supplier lifecycle management
Kelun-Biotech and Crescent Biopharma forged a collaboration covering SKB105/CR-003 and SKB118, a PD-1 x VEGF bispecific antibody also known as CR-001
Cidara will become a wholly owned subsidiary of Merck and the common stock of Cidara will no longer be listed or traded on the Nasdaq Global Market
Rajdeep is an accomplished business leader with a strong techno-commercial background in the healthcare and diagnostic sector
Our scientists found that toxicological data for most PFAS are incomplete or unavailable, leaving significant uncertainty about consumer safety
Dr. Chand held several leadership positions within AstraZeneca and the broader biopharmaceutical industry
Dr. Bandichhor brings nearly two decades of experience from Dr. Reddy's Laboratories
Leaders from science, policy, industry, and investment came together in New Delhi to examine how alignment across the biotechnology value chain can turn innovation into outcomes at scale
The portfolio, purchased from a leading multinational generic manufacturer, addresses a market valued at $473.2 million for the 12 months ending August 2025
The company’s consolidated revenue from operations rose to Rs. 361.13 crore in Q2 FY26 and Rs. 707.67 crore for the first half
Subscribe To Our Newsletter & Stay Updated
